Recent Finacing
Recent Raise
Anchor Therapeutics is a preclinical drug discovery and development company developing pepducin peptide therapeutics to modulate hard-to-drug G protein‑coupled receptors (GPCRs).
Focus Areas
Recent Investors
Total Raised
Funding round
Investors